Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088976686> ?p ?o ?g. }
- W3088976686 endingPage "5458" @default.
- W3088976686 startingPage "5449" @default.
- W3088976686 abstract "Abstract Next-generation genomic sequencing has identified multiple novel molecular alterations in cancer. Since the identification of DNA methylation and histone modification, it has become evident that genes encoding epigenetic modifiers that locally and globally regulate gene expression play a crucial role in normal development and cancer progression. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) is the enzymatic catalytic subunit of the polycomb-repressive complex 2 (PRC2) that can alter gene expression by trimethylating lysine 27 on histone 3 (H3K27). EZH2 is involved in global transcriptional repression, mainly targeting tumor-suppressor genes. EZH2 is commonly overexpressed in cancer and shows activating mutations in subtypes of lymphoma. Extensive studies have uncovered an important role for EZH2 in cancer progression and have suggested that it may be a useful therapeutic target. In addition, tumors harboring mutations in other epigenetic genes such as ARID1A, KDM6, and BAP1 are highly sensitive to EZH2 inhibition, thus increasing its potential as a therapeutic target. Recent studies also suggest that inhibition of EZH2 enhances the response to tumor immunotherapy. Many small-molecule inhibitors have been developed to target EZH2 or the PRC2 complex, with some of these inhibitors now in early clinical trials reporting clinical responses with acceptable tolerability. In this review, we highlight the recent advances in targeting EZH2, its successes, and potential limitations, and we discuss the future directions of this therapeutic subclass." @default.
- W3088976686 created "2020-10-01" @default.
- W3088976686 creator A5014189154 @default.
- W3088976686 creator A5048114193 @default.
- W3088976686 creator A5079699559 @default.
- W3088976686 creator A5079917691 @default.
- W3088976686 date "2020-12-15" @default.
- W3088976686 modified "2023-10-17" @default.
- W3088976686 title "EZH2-Targeted Therapies in Cancer: Hype or a Reality" @default.
- W3088976686 cites W1963736125 @default.
- W3088976686 cites W1971313898 @default.
- W3088976686 cites W1982056010 @default.
- W3088976686 cites W1985003152 @default.
- W3088976686 cites W1985445406 @default.
- W3088976686 cites W1986418310 @default.
- W3088976686 cites W1990711772 @default.
- W3088976686 cites W1996487270 @default.
- W3088976686 cites W1998639983 @default.
- W3088976686 cites W2001488290 @default.
- W3088976686 cites W2004380688 @default.
- W3088976686 cites W2009858080 @default.
- W3088976686 cites W2010790480 @default.
- W3088976686 cites W2013149980 @default.
- W3088976686 cites W2016644845 @default.
- W3088976686 cites W2020230403 @default.
- W3088976686 cites W2022093187 @default.
- W3088976686 cites W2022237004 @default.
- W3088976686 cites W2024373518 @default.
- W3088976686 cites W2024985626 @default.
- W3088976686 cites W2025856640 @default.
- W3088976686 cites W2030337250 @default.
- W3088976686 cites W2033478449 @default.
- W3088976686 cites W2033562493 @default.
- W3088976686 cites W2034340491 @default.
- W3088976686 cites W2037548653 @default.
- W3088976686 cites W2038676786 @default.
- W3088976686 cites W2039904177 @default.
- W3088976686 cites W2040182688 @default.
- W3088976686 cites W2043206390 @default.
- W3088976686 cites W2048122601 @default.
- W3088976686 cites W2053116646 @default.
- W3088976686 cites W2054301876 @default.
- W3088976686 cites W2060608189 @default.
- W3088976686 cites W2063851753 @default.
- W3088976686 cites W2067155951 @default.
- W3088976686 cites W2069237225 @default.
- W3088976686 cites W2072035127 @default.
- W3088976686 cites W2072466432 @default.
- W3088976686 cites W2083255319 @default.
- W3088976686 cites W2084295010 @default.
- W3088976686 cites W2085178889 @default.
- W3088976686 cites W2100071542 @default.
- W3088976686 cites W2100365251 @default.
- W3088976686 cites W2100630390 @default.
- W3088976686 cites W2101370480 @default.
- W3088976686 cites W2103021272 @default.
- W3088976686 cites W2104425103 @default.
- W3088976686 cites W2107874457 @default.
- W3088976686 cites W2108381095 @default.
- W3088976686 cites W2108549889 @default.
- W3088976686 cites W2110957729 @default.
- W3088976686 cites W2113035823 @default.
- W3088976686 cites W2114354078 @default.
- W3088976686 cites W2116318886 @default.
- W3088976686 cites W2119079421 @default.
- W3088976686 cites W2125496315 @default.
- W3088976686 cites W2132310381 @default.
- W3088976686 cites W2143252333 @default.
- W3088976686 cites W2147370638 @default.
- W3088976686 cites W2148033929 @default.
- W3088976686 cites W2148102207 @default.
- W3088976686 cites W2152099890 @default.
- W3088976686 cites W2160689782 @default.
- W3088976686 cites W2163217325 @default.
- W3088976686 cites W2164052369 @default.
- W3088976686 cites W2166907165 @default.
- W3088976686 cites W2171439874 @default.
- W3088976686 cites W2176126538 @default.
- W3088976686 cites W2202401513 @default.
- W3088976686 cites W2238488506 @default.
- W3088976686 cites W2264682687 @default.
- W3088976686 cites W2280718773 @default.
- W3088976686 cites W2310558276 @default.
- W3088976686 cites W2427007523 @default.
- W3088976686 cites W2460529418 @default.
- W3088976686 cites W2484616545 @default.
- W3088976686 cites W2530871695 @default.
- W3088976686 cites W2567190685 @default.
- W3088976686 cites W2584632839 @default.
- W3088976686 cites W2590039001 @default.
- W3088976686 cites W2590871167 @default.
- W3088976686 cites W2592550395 @default.
- W3088976686 cites W2593741942 @default.
- W3088976686 cites W2617455688 @default.
- W3088976686 cites W2726891392 @default.
- W3088976686 cites W2737220388 @default.
- W3088976686 cites W2766207308 @default.
- W3088976686 cites W2775830266 @default.